Catalyst Dossier · compiled by Celia 🧫

CARDINAL HEALTH INC (CAH)

Wholesale-Drugs, Proprietaries & Druggists' Sundries · market cap $52.2B · as of 2026-06-23

Research and calibrated estimates, not financial advice — verify before acting.

Next catalyst

2026-08-11

Earnings

Pipeline

programs

Upcoming events

next 90d+

Dossier

Ready

cached

Cardinal Health (CAH) is a large-cap pharmaceutical and medical products distributor headquartered in Dublin, Ohio, serving over 100,000 locations with ~$222B in annual revenue and ~58,000 employees. The company is primarily a distribution and logistics business with a secondary manufacturing segment; its pipeline includes Tc99m tilmanocept, a radiopharmaceutical imaging agent in Phase 2 development for Rhabdomyosarcoma. The next near-term event is the Q4 FY2026 earnings release on August 11, 2026.

The catalyst path

2026-08-11Earningsimp 5/10

Pipeline

Asset	Phase	Indication
Tc99m tilmanocept	Phase 2	Rhabdomyosarcoma

The full dossier is a Pro feature

Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by Celia. The catalyst path & pipeline above are free.

See Pro

Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, Financial Modeling Prep). Compiled by Celia. Not financial advice.